ESAs
Advertisement
Variations in Health Plan Coverage of ESAs for Anemia in CKD
Victoria SochaAnemia and Kidney Disease | February 5, 2024
NikoLetta M. Margaretos, BA, and colleagues conducted a study to examine policies among commercial health plans for ...
Read More
ESA Use in Patients with Non-Dialysis Dependent CKD
Victoria SochaChronic Kidney Disease | April 19, 2023
NKF Spring Clinical Meetings ...
Read More
Prevalence of Anemia in Patients with Non-Dialysis Dependent CKD
Victoria SochaChronic Kidney Disease | April 11, 2023
Kidney Week 2020 ...
Read More
Long-acting Anemia Treatment May Stabilize Hemoglobin Levels
Victoria SochaNational Kidney Foundation 2020 | April 19, 2023
There are few scientific-based data comparing clinical outcomes of erythropoiesis-stimulating agents (ESAs) in patients ...
Read More
Advertisement
Advertisement
Advertisement
Latest News

Reduced-Dose Apixaban Anticoagulation Noninferior to Full Dose in Prevention of Cancer-Associated VTE

April 11, 2025

FDA Approval for Commercial Large-Diameter Thoracic Tapered Implant

April 11, 2025

Do Neuroimaging Gaps Exist in Developmental Disabilities?

April 10, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |